High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial.

Lancet Reg Health Eur · 2023 · PMC9627534 · PMID 36337437

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

Taken together, and despite observing a slight trend towards CoQ10 having potentially beneficial effects, we found no overall significant effects of CoQ10 compared to placebo.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.